Potentiation of Antiglioma Effect With Combined Temozolomide and Interferon-Β

Oncology Reports - Greece
doi 10.3892/or.16.6.1253
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Effect of Combined Anti-Pd-1 and Temozolomide Therapy in Glioblastoma

OncoImmunology
OncologyAllergyImmunology
2018English

Interferon-Β (IFNB; IFN-β)

Science-Business eXchange
2014English

Inhibition of Telomerase Increases Resistance of Melanoma Cells to Temozolomide, but Not to Temozolomide Combined With Poly (ADP-Ribose) Polymerase Inhibitor

Molecular Pharmacology
Molecular MedicinePharmacology
2003English

Two Phase II Trials of Temozolomide With Interferon-Α2b (Pegylated and Non-Pegylated) in Patients With Recurrent Glioblastoma Multiforme

British Journal of Cancer
Cancer ResearchOncology
2009English

Effect of the Β-Lactamase Inhibitor Vaborbactam Combined With Meropenem Against Serine Carbapenemase-Producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan

Clinical Cancer Research
Cancer ResearchOncology
2006English

Inhibiting Stemness and Invasive Properties of Glioblastoma Tumorsphere by Combined Treatment With Temozolomide and a Newly Designed Biguanide (HL156A)

Oncotarget
Oncology
2016English

Benefits Afforded by Combined Temozolomide, Radiation and Stem Cell Strategy for Glioma Therapy

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2017English

Efficacy of Interferon Combined Glycyrrhizin Therapy in Patients With Chronic Hepatitis C.

Acta Hepatologica Japonica
Hepatology
1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy